Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes.

Literature DB >> 9211341

Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes.

A G Bostom¹, L Lathrop.

Abstract

Entities: Disease

Mesh：

Substances：
Homocysteine

Year: 1997 PMID： 9211341 DOI： 10.1038/ki.1997.298

Source DB: PubMed Journal: Kidney Int ISSN： 0085-2538 Impact factor: 10.612

Keyword Cloud
Cited

× No keyword cloud information.

43 in total

Review 1. Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease.

Authors: M J Sarnak; A S Levey
Journal: J Thromb Thrombolysis Date: 2000-10 Impact factor: 2.300

2. Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography.

Authors: Gholamreza Davoodi; Samira Mehrabi Pari; Mehrnaz Rezvanfard; Mahmood Sheikh Fathollahi; Manouchehr Amini; Elham Hakki; Ali Kazemisaeid; Ahmad Yaminisharif
Journal: Int Urol Nephrol Date: 2011-10-16 Impact factor: 2.370

3. Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia.

Authors: Sabena M Conley; Justine M Abais-Battad; Xinxu Yuan; Qinghua Zhang; Krishna M Boini; Pin-Lan Li
Journal: Free Radic Biol Med Date: 2017-02-11 Impact factor: 7.376

Review 4. Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.

Authors: D A Stehouwer
Journal: Drugs Aging Date: 2000-04 Impact factor: 3.923

5. Effect of homocysteine thiolactone on structure and aggregation propensity of bovine pancreatic insulin.

Authors: Shima Jalili; Reza Yousefi; Mohammad-Mehdi Papari; Ali Akbar Moosavi-Movahedi
Journal: Protein J Date: 2011-06 Impact factor: 2.371

6. Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).

Authors: Maple M Fung; Rany M Salem; Michael S Lipkowitz; Vibha Bhatnagar; Braj Pandey; Nicholas J Schork; Daniel T O'Connor
Journal: Nephrol Dial Transplant Date: 2011-05-25 Impact factor: 5.992

Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes.

Review 1. Epidemiology, diagnosis, and management of cardiac disease in chronic renal disease.

2. Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography.

3. Contribution of guanine nucleotide exchange factor Vav2 to NLRP3 inflammasome activation in mouse podocytes during hyperhomocysteinemia.

Review 4. Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.

5. Effect of homocysteine thiolactone on structure and aggregation propensity of bovine pancreatic insulin.

6. Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC).

7. Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients.

Review 8. Mechanisms of homocysteine-induced glomerular injury and sclerosis.

9. Homocysteine and left ventricular hypertrophy in children with chronic renal failure.

Review 10. Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk.